ChemBriefBioNexus Gene Lab Files Initial Beneficial Ownership Statement for Fidelion Diagnostics Pte. Ltd
BioNexus Gene Lab Corp filed a Form 3 statement revealing Fidelion Diagnostics Pte. Ltd holds over 5% of common shares. The filing identifies Fidelion as a greater-than-5% holder with 392,329 shares a
Bitget · 2026-08-07 12:40